IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,459,000 | -31.5% | 25,809 | -42.5% | 0.01% | -38.5% |
| Q3 2020 | $2,131,000 | -6.0% | 44,919 | +16.8% | 0.01% | -7.1% |
| Q2 2020 | $2,267,000 | -36.7% | 38,449 | -49.2% | 0.01% | -46.2% |
| Q1 2020 | $3,581,000 | -73.1% | 75,733 | -63.5% | 0.03% | -71.4% |
| Q2 2019 | $13,319,000 | -20.9% | 207,238 | -0.2% | 0.09% | -19.5% |
| Q1 2019 | $16,848,000 | +50.1% | 207,565 | 0.0% | 0.11% | +34.5% |
| Q4 2018 | $11,221,000 | +8.2% | 207,565 | +3.3% | 0.08% | +47.4% |
| Q3 2018 | $10,366,000 | +19.4% | 200,977 | -3.6% | 0.06% | +11.8% |
| Q2 2018 | $8,684,000 | -7.3% | 208,405 | -1.9% | 0.05% | -10.5% |
| Q1 2018 | $9,364,000 | -12.8% | 212,425 | -0.5% | 0.06% | -6.6% |
| Q4 2017 | $10,740,000 | +2.4% | 213,524 | +3.3% | 0.06% | +8.9% |
| Q3 2017 | $10,484,000 | +2.9% | 206,784 | +3.3% | 0.06% | -1.8% |
| Q2 2017 | $10,187,000 | – | 200,258 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |